Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-004659

Chief Legal Officer acquired 5,187 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gardiner Nathaniel S. Chief Legal Officer 2024-02-26 Option exercise +5,187 $8.99 $46,631 75,688 D
Derivatives
Gardiner Nathaniel S. Chief Legal Officer 2024-02-26 Option exercise · Stock Option (Right to Buy) −5,187 77,813 D
Loading xslF345X05/form4.xml…